1Spiegelman BM.PPAR-gamma:adipogenic regular and thiazolidinedione receptor.Diabetes,1998,47:507-514.
2Lebovitz HE,Dole JE,Patwardhan R,et al.Rosiglitazone monotherapy is effective in patients with type 2 diabetes.J Clin Endocrinol Metab,2001,86:280-288.
4Margaret K,Elizabeth M,Jai P:Rosiglitazone is safe and well tolerated as monotherapy or combination therapy in patients with type 2 diabetes mellitus.Abstracts from the 59th scientific session,A117:0505.